hat
NCT02484092. Terapi jèn, Open-Label, etid Dòz-Eskalasyon nan SPK-9001 [Adeno-Associated vektè viral Avèk Imèn moun faktè IX] Nan sijè ki gen emofil B. https://clinicaltrials.gov/ct2/show/NCT02484092
deu
NCT02484092. Gentherapie, Open-Label, Dosis-Eskalations-Studie von SPK-9001 [Adeno-assoziierter viraler Vektor mit humanem Faktor IX-Gen] bei Patienten mit Hämophilie B. https://clinicaltrials.gov/ct2/show/NCT02484092